Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Review of the epidemiological literature on antidepressant use and breast cancer risk.

Coogan PF.

Expert Rev Neurother. 2006 Sep;6(9):1363-74. Review.

PMID:
17009923
[PubMed - indexed for MEDLINE]
2.

Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer.

Lawlor DA, Jüni P, Ebrahim S, Egger M.

J Clin Epidemiol. 2003 Feb;56(2):155-63. Review.

PMID:
12654410
[PubMed - indexed for MEDLINE]
3.

Use of antidepressant medications and the possible association with breast cancer risk. A review.

Bahl S, Cotterchio M, Kreiger N.

Psychother Psychosom. 2003 Jul-Aug;72(4):185-94. Review.

PMID:
12792123
[PubMed - indexed for MEDLINE]
4.

Use of common medications and breast cancer risk.

Moysich KB, Beehler GP, Zirpoli G, Choi JY, Baker JA.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1564-95. doi: 10.1158/1055-9965.EPI-07-2828. Review.

PMID:
18628410
[PubMed - indexed for MEDLINE]
Free Article
5.

Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates.

Brandes LJ.

Crit Rev Toxicol. 2005 Jul;35(6):587-92. Review.

PMID:
16422394
[PubMed - indexed for MEDLINE]
6.

Progestin and breast cancer. The missing pieces of a puzzle.

Giersig C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):782-6. doi: 10.1007/s00103-008-0586-6. Review. Erratum in: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Aug;51(8):946.

PMID:
18592338
[PubMed - indexed for MEDLINE]
7.

Antidepressants and the risk of breast cancer.

Kurdyak PA, Gnam WH, Streiner DL.

Can J Psychiatry. 2002 Dec;47(10):966-70. Review.

PMID:
12553133
[PubMed - indexed for MEDLINE]
8.
9.

Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?

Schover LR.

Fertil Steril. 2008 Jul;90(1):129-40. Epub 2007 Nov 26. Review.

PMID:
18023435
[PubMed - indexed for MEDLINE]
10.

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH.

J Clin Psychiatry. 2006 Dec;67(12):1836-55. Review.

PMID:
17194261
[PubMed - indexed for MEDLINE]
11.

Antidepressants and falls in the elderly.

Darowski A, Chambers SA, Chambers DJ.

Drugs Aging. 2009;26(5):381-94. doi: 10.2165/00002512-200926050-00002. Review.

PMID:
19552490
[PubMed - indexed for MEDLINE]
12.

Role of MRI in screening women at high risk for breast cancer.

Lehman CD.

J Magn Reson Imaging. 2006 Nov;24(5):964-70. Review.

PMID:
17036340
[PubMed - indexed for MEDLINE]
13.

How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

Hall WD, Lucke J.

Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):941-50. Review.

PMID:
17054562
[PubMed - indexed for MEDLINE]
14.

Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?

Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S.

Cancer. 2007 Jun 15;109(12 Suppl):2627-34. Review.

PMID:
17503444
[PubMed - indexed for MEDLINE]
Free Article
15.

Is amisulpride safe when prescribed to breast and prostate cancer patients?

Pasquini M, Berardelli I, Calabrò F, Roselli V, Hefner S, Biondi M.

Med Hypotheses. 2013 Dec;81(6):1146-50. doi: 10.1016/j.mehy.2013.08.031. Epub 2013 Sep 18. Review.

PMID:
24134827
[PubMed - indexed for MEDLINE]
16.

Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.

Lester J.

Clin J Oncol Nurs. 2007 Oct;11(5):619-22. Review.

PMID:
17962169
[PubMed - indexed for MEDLINE]
Free Article
17.

[Epidemiologic data on radiation-induced breast cancer].

Telle-Lamberton M.

Rev Epidemiol Sante Publique. 2008 Aug;56(4):235-43. doi: 10.1016/j.respe.2008.05.024. Epub 2008 Jul 30. Review. French.

PMID:
18672338
[PubMed - indexed for MEDLINE]
18.

Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.

Cosgrove L, Shi L, Creasey DE, Anaya-McKivergan M, Myers JA, Huybrechts KF.

PLoS One. 2011 Apr 6;6(4):e18210. doi: 10.1371/journal.pone.0018210. Review.

PMID:
21494667
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Hormonal breast cancer agents: implications for the primary care provider.

Lyon DE, Roux G, Voll S.

J Am Acad Nurse Pract. 2006 Nov;18(11):518-23. Review.

PMID:
17064329
[PubMed - indexed for MEDLINE]
20.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk